All DealsPortfolioLooking to fundraise?Back To CQRS

Welcome to the CQRS Investment Platform

Matching Sophisticated Investors with early stage, high growth companies

Creating Quality

Supporting The Journey Partner

We enable entrepreneurs to build their businesses

CQRS advises unlisted businesses, regarding their structure and preparation for investment. We help entrepreneurs navigate the maze of legal, financial, organisational and business planning thereby enabling better decision making and clear documentation which is essential for growth and securing funding.

For the investor, CQRS creates opportunities to access the Sponsored Businesses and make contact with other investors who may be participating in the funding. CQRS and Partners may participate in the financing of some of these businesses. In addition, we provide services for investors which enable them to centralise certain administrative functions, thereby providing efficiencies and security.

CQRS partners represent a diverse talent pool. The CQRS team members have an abundance of business experience and provide perspective on strategy and market context for all investment opportunities. Commonly sponsored businesses invite a CQRS partner to join their board to help ensure that the business receives the full benefit of CQRS support.


Hox Therapeutics

Equity
EIS

HTL has developed a peptide and a small molecule compound. The peptide causes rapid cell death in in-vitro and in-vivo models in 14 different cancers

Valuation:

£9,750,000

Sector:

Healthcare

Stage:

Other

Target
£4,500,000

OUR PARTNERS

ABOUT

CQRS Limited is a limited liability company, registered in England with number 08521440 and is authorised by the Financial Conduct Authority, Firm Reference Number 764618.

FURTHER INFORMATION

DisclaimerPrivacy PolicyRisk Warning

IMPORTANT INFORMATION

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. CQRS does not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.Please click here to see the full Risk Warning.

© 2020 CQRS. All rights reserved.

Powered by ENVESTRY

Sqreen | Runtime Application Protection

By using our site, you acknowledge that you have read and understand our Privacy and Cookie Policy